Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases

被引:10
|
作者
Miyazaki, Tatsuya [1 ]
Sohda, Makoto [1 ]
Sakai, Makoto [1 ]
Kumakura, Yuji [1 ]
Yoshida, Tomonori [1 ]
Kuriyama, Kengo [1 ]
Yokobori, Takehiko [2 ]
Miyazaki, Masaya [3 ]
Hirato, Junko [4 ]
Okumura, Toshiyuki [5 ]
Ishikawa, Hitoshi [5 ]
Sakurai, Hideyuki [5 ]
Kuwano, Hiroyuki [1 ]
机构
[1] Gunma Univ, Grad Sch, Dept Gen Surg Sci, Maebashi, Gunma, Japan
[2] Gunma Univ, Grad Sch, Dept Mol Pharmacol & Oncol, Maebashi, Gunma, Japan
[3] Gunma Univ, Grad Sch, Dept Diagnost & Intervent Radiol, Maebashi, Gunma, Japan
[4] Gunma Univ, Grad Sch, Dept Pathol, Maebashi, Gunma, Japan
[5] Univ Tsukuba, Fac Med, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan
基金
日本学术振兴会;
关键词
alpha-fetoprotein; Barrett's cancer; proton beam therapy; HEPATOID ADENOCARCINOMA; CONCURRENT CHEMOTHERAPY; TUBULAR ADENOCARCINOMA; BARRETTS-ESOPHAGUS; CHEMORADIOTHERAPY; CRYOABLATION; CARCINOMA; ALCOHOL; TRIAL;
D O I
10.2169/internalmedicine.0270-17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 50-year-old man who presented with a fever and epigastralgia was diagnosed to have esophageal carcinoma which was identified as poorly differentiated adenocarcinoma producing alpha-fetoprotein (AFP) with Barrett's esophagus. Computed tomography revealed multiple liver metastases and lymph node metastases surrounding the stomach. We first performed chemotherapy for the systemic lesions and proton beam therapy for the local control of lesions without complete remission and we were able to successfully control the frequently recurring lesions by proton beam therapy, cryotherapy and chemotherapy. A complete response has been maintained for 16 months and the overall survival time is 4 years and 2 months. Proton beam therapy for primary esophageal cancer and metastatic lesions was thus found to be an effective therapeutic option for such cases.
引用
收藏
页码:2333 / 2339
页数:7
相关论文
共 50 条
  • [31] Proton Beam Therapy for Lung Oligometastatic Recurrence in Patients With Esophageal Cancer
    Yamaguchi, Hisashi
    Kato, Takahiro
    Honda, Michitaka
    Hamada, Koichi
    Ishikawa, Yojiro
    Seto, Ichiro
    Takagawa, Yoshiaki
    Suzuki, Motohisa
    Kikuchi, Yasuhiro
    Murakami, Masao
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [32] Hypofractionated proton therapy reduces beam on time in esophageal cancer patients
    Klinker, Petra
    Free, Jeffrey
    Marmitt, Gabriel Guterres
    Dieters, Margriet
    Ijsbrandy, Charlotte
    Beukema, Jannet C.
    Korevaar, Erik W.
    Langendijk, Johannes A.
    Muijs, Christina T.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5980 - S5982
  • [33] Clinical results of proton beam therapy for locoregionally advanced esophageal cancer
    Sugahara, S.
    Tokuuye, K.
    Nakahara, A.
    Hata, M.
    Terashima, H.
    Fukumitsu, N.
    Shibahara, T.
    Nakayama, H.
    Hashimoto, T.
    Ohara, K.
    Akine, Y.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S358 - S358
  • [34] Proton beam therapy for cancer
    Tsang, Derek S.
    Patel, Samir
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (24) : E664 - E666
  • [35] Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer
    Van Daele, Elke
    Scuderi, Vincenzo
    Pape, Eva
    Van De Putte, Dirk
    Varin, Oswald
    Van Nieuwenhove, Yves
    Ceelen, Wim
    Troisi, Roberto
    Pattyn, Piet
    ACTA CHIRURGICA BELGICA, 2018, 118 (04) : 227 - 232
  • [36] Proton Beam Therapy in Liver Malignancies
    Osman Siddiqui
    Ariel Pollock
    Santanu Samanta
    Adeel Kaiser
    Jason K. Molitoris
    Current Oncology Reports, 2020, 22
  • [37] Proton beam therapy for liver cancers
    Chuong, Michael
    Kaiser, Adeel
    Molitoris, Jason
    Romero, Alejandra Mendez
    Apisarnthanarax, Smith
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (01) : 157 - 165
  • [38] Proton Beam Therapy in Liver Malignancies
    Siddiqui, Osman
    Pollock, Ariel
    Samanta, Santanu
    Kaiser, Adeel
    Molitoris, Jason K.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (03)
  • [39] Stereotactic body proton therapy for liver metastases
    Kang, Joseph I., Jr.
    Ling, Ted C.
    Slater, Jerry D.
    Yang, Gary Y.
    TRANSLATIONAL CANCER RESEARCH, 2012, 1 (04) : 271 - 275
  • [40] The role of proton therapy in esophageal cancer
    Crehange, G.
    Goudjil, F.
    Krhili, S. L.
    Minsat, M.
    de Marzi, L.
    Dendale, R.
    CANCER RADIOTHERAPIE, 2022, 26 (04): : 604 - 610